Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank75
Studio
Year-over-Year Change

Price to free cash flow ratio

Percentile
P75
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-5.70+32.9%
2024-8.50-141.3%
202320.56+207.5%
2022-19.12-30.6%
2021-14.64-